The role of salt intake and salt sensitivity in the management of hypertension in South Asian people with chronic kidney disease: a randomised controlled trial

Ione de Brito-Ashurst, Lin Perry, Thomas A B Sanders, Jane E Thomas, Hamish Dobbie, Mira Varagunam, Muhammad M Yaqoob, Ione de Brito-Ashurst, Lin Perry, Thomas A B Sanders, Jane E Thomas, Hamish Dobbie, Mira Varagunam, Muhammad M Yaqoob

Abstract

Background: The effectiveness of salt restriction to lower blood pressure (BP) in Bangladeshi patients with chronic kidney disease (CKD) is uncertain.

Objective: To test the hypothesis that a tailored intervention intended to reduce salt intake in addition to standard care will achieve a greater reduction in BP in UK Bangladeshi patients with CKD than standard care alone.

Design: A randomised parallel-group controlled trial conducted over a 6 month period.

Setting: A tertiary renal unit based in acute care hospital in East London.

Participants: 56 adult participants of Bangladeshi origin with CKD and BP >130/80 mm Hg or on antihypertensive medication.

Intervention: Participants were randomly allocated to receive a tailored low-salt diet or the standard low-salt advice. BP medication, physical activity and weight were monitored.

Main outcome measures: The primary outcome was change in ambulatory BP. Adherence to dietary advice was assessed by measurement of 24 h urinary salt excretion.

Results: Of 56 participants randomised, six withdrew at the start of the study. During the study, one intervention group participant died, one control group participant moved to Bangladesh. Data were available for the primary endpoint on 48 participants. Compared with control group the intervention urinary sodium excretion fell from 260 mmol/d to 103 mmol/d (-131 to -76, p<0.001) at 6 months and resulted in mean (95% CI) falls in 24 h systolic/diastolic BP of -8 mm Hg (-11 to -5)/2 (-4 to -2) both p<0.001.

Conclusions: A tailored intervention can achieve moderate salt restriction in patients with CKD, resulting in clinically meaningful falls in BP independent of hypertensive medication.

Trial registration: ClinicalTrials.gov NCT00702312.

Keywords: Renal Disease.

Figures

Figure 1
Figure 1
CONSORT flow chart of participant recruitment, allocation and assessment.
Figure 2
Figure 2
24 h urinary sodium excretion for intervention and control groups is shown as the mean difference with 95% CI in parenthesis. All differences are p

Figure 3

Changes in daytime and night-time…

Figure 3

Changes in daytime and night-time systolic blood pressure (SBP) and diastolic blood pressure…

Figure 3
Changes in daytime and night-time systolic blood pressure (SBP) and diastolic blood pressure (DBP). Mean values and changes with 95% CI. All differences are p
Similar articles
Cited by
References
    1. Roderick PJ, Jones I, Raleigh VS, et al. Population need for renal replacement therapy in Thames regions: ethnic dimension. BMJ 1994;309:1111–14 - PMC - PubMed
    1. Saweirs WW, Goddard J. What are the best treatments for early chronic kidney disease? A background paper prepared for the UK consensus conference on early chronic kidney disease. Nephrol Dial Transplant 2007;22(Suppl 9):ix31–38 - PubMed
    1. Chen CH, Lin YP, Yu WC, et al. Volume status and blood pressure during long-term hemodialysis: role of ventricular stiffness. Hypertension 2003;42:257–62 - PubMed
    1. De Brito-Ashurst I, Perry L, Sanders TA, et al. Dietary salt intake of Bangladeshi patients with kidney disease in East London: an exploratory case study. E-J Clninical Nutrition Metabolism 2009;4:e35–40
    1. Agency FS. Why 6g? A summary of the scientific evidence for the salt intake target Medical Research Council. Human Nutrition Research. 2005; Available from: http://www.food.gov.uk/
Show all 28 references
Publication types
MeSH terms
Associated data
Full text links [x]
[x]
Cite
Copy Download .nbib
Format: AMA APA MLA NLM
Figure 3
Figure 3
Changes in daytime and night-time systolic blood pressure (SBP) and diastolic blood pressure (DBP). Mean values and changes with 95% CI. All differences are p

References

    1. Roderick PJ, Jones I, Raleigh VS, et al. Population need for renal replacement therapy in Thames regions: ethnic dimension. BMJ 1994;309:1111–14
    1. Saweirs WW, Goddard J. What are the best treatments for early chronic kidney disease? A background paper prepared for the UK consensus conference on early chronic kidney disease. Nephrol Dial Transplant 2007;22(Suppl 9):ix31–38
    1. Chen CH, Lin YP, Yu WC, et al. Volume status and blood pressure during long-term hemodialysis: role of ventricular stiffness. Hypertension 2003;42:257–62
    1. De Brito-Ashurst I, Perry L, Sanders TA, et al. Dietary salt intake of Bangladeshi patients with kidney disease in East London: an exploratory case study. E-J Clninical Nutrition Metabolism 2009;4:e35–40
    1. Agency FS. Why 6g? A summary of the scientific evidence for the salt intake target Medical Research Council. Human Nutrition Research. 2005; Available from:
    1. Taylor RS, Ashton KE, Moxham T, et al. Reduced dietary salt for the prevention of cardiovascular disease. Cochrane Database Syst Rev 2011(7):CD009217.
    1. He FJ, MacGregor GA. Effect of modest salt reduction on blood pressure: a meta-analysis of randomized trials. Implications for public health. J Hum Hypertens 2002;16:761–70
    1. Calhoun DA, Jones D, Textor S, et al. Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Circulation 2008;117:e510–26
    1. Pimenta E, Gaddam KK, Oparil S, et al. Effects of dietary sodium reduction on blood pressure in subjects with resistant hypertension: results from a randomized trial. Hypertension 2009;54:475–81
    1. de Brito-Ashurst I, Perry L, Sanders TA, et al. Barriers and facilitators of dietary sodium restriction amongst Bangladeshi chronic kidney disease patients. J Hum Nutr Diet 2011;24:86–95
    1. Community Kitchen UK, CKUK Improving diet and health in vulnerable communities with fresh food, friendship & fun. 2008. Available from HYPERLINK ""
    1. O'Brien E, Asmar R, Beilin L, et al. European Society of Hypertension recommendations for conventional, ambulatory and home blood pressure measurement. J Hypertens 2003;21:821–48
    1. Ryan CG, Grant PM, Tigbe WW, et al. The validity and reliability of a novel activity monitor as a measure of walking. Br J Sports Med 2006;40:779–84
    1. Appel LJ, Champagne CM, Harsha DW, et al. Effects of comprehensive lifestyle modification on blood pressure control: main results of the PREMIER clinical trial. JAMA 2003;289:2083–93
    1. Health Do White paper: Choosing health—making healthy choices easier. London: DoH, 2004
    1. Forte JG, Miguel JM, Miguel MJ, et al. Salt and blood pressure: a community trial. J Hum Hypertens 1989;3:179–84
    1. Ni H, Nauman D, Burgess D, et al. Factors influencing knowledge of and adherence to self-care among patients with heart failure. Arch Intern Med 1999;159:1613–19
    1. Masango M, Khokhar S. Domestic use of salt shows high salt consumption in Black Africans and Indian Asians associated with a very low awareness level of national salt guidelines. Proceedings of the Nutrition Society, 2009:E153
    1. Paoletti E, Bellino D, Amidone M, et al. Relationship between arterial hypertension and renal damage in chronic kidney disease: insights from ABPM. J Nephrol 2006;19:778–82
    1. Shimada K, Kawamoto A, Matsubayashi K, et al. Silent cerebrovascular disease in the elderly. Correlation with ambulatory pressure. Hypertension 1990;16:692–9
    1. Timio M, Venanzi S, Lolli S, et al. "Non-dipper" hypertensive patients and progressive renal insufficiency: a 3-year longitudinal study. Clin Nephrol 1995;43:382–7
    1. Fagard RH, Celis H, Thijs L, et al. Daytime and nighttime blood pressure as predictors of death and cause-specific cardiovascular events in hypertension. Hypertension 2008;51:55–61
    1. Verdecchia P, Porcellati C, Schillaci G, et al. Ambulatory blood pressure. An independent predictor of prognosis in essential hypertension. Hypertension 1994;24:793–801
    1. Damasceno A, Caupers P, Santos A, et al. Influence of salt intake on the daytime-nighttime blood pressure variation in normotensive and hypertensive black subjects. Rev Port Cardiol 2000;19:315–29
    1. Ganda OP, Fonseca VA. Salt sensitivity, insulin resistance, and public health in India. Endocr Pract 2010;16:940–4
    1. MacGregor GA, Markandu ND, Sagnella GA, et al. Double-blind study of three sodium intakes and long-term effects of sodium restriction in essential hypertension. Lancet 1989;2:1244–7
    1. Cappuccio FP, Markandu ND, Carney C, et al. Double-blind randomised trial of modest salt restriction in older people. Lancet 1997;350:850–4
    1. Slagman MC, Waanders F, Hemmelder MH, et al. Moderate dietary sodium restriction added to angiotensin converting enzyme inhibition compared with dual blockade in lowering proteinuria and blood pressure: randomised controlled trial. BMJ 2011;343:d4366.

Source: PubMed

Sponsor e collaboratori

Condizioni mediche

Interventi farmacologici

3
Sottoscrivi